Moreover, the activation of PPARγ decreased the expression of iNOS and increased the expression of Arg‐1, Fizz 1, and Ym 1 by inhibiting STAT‐1 phosphorylation and promoting STAT‐6 phosphorylation in mice with DSS‐induced IBD. Here, PPARG is linked to inflammatory bowel disease.